Johnson & Johnson $ 162.38 -0.4 (-0.25%)
Volume:
6,741,521
Avg Vol (1m):
7,763,522
Market Cap $:
427.47 Bil
Enterprise Value $:
434.45 Bil
P/E (TTM):
25.53
P/B:
6.64
Current and historical daily P/E ratio for JNJ (Johnson & Johnson) from 1990 to Jan 20 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Johnson & Johnson stock (JNJ) PE ratio as of Jan 20 2021 is 25.53.
More Details
Johnson & Johnson PE Ratio (TTM) Chart
EMBED
Johnson & Johnson PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1256
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Johnson & Johnson PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2021-01-21 | 25.5 | 2020-11-19 | 23.1 |
2021-01-20 | 25.5 | 2020-11-18 | 23.2 |
2021-01-19 | 25.6 | 2020-11-17 | 23.5 |
2021-01-18 | 25.2 | 2020-11-16 | 23.7 |
2021-01-15 | 25.2 | 2020-11-13 | 23.6 |
2021-01-14 | 25.3 | 2020-11-12 | 23.3 |
2021-01-13 | 24.8 | 2020-11-11 | 23.2 |
2021-01-12 | 24.9 | 2020-11-10 | 23.3 |
2021-01-11 | 25.1 | 2020-11-09 | 23.0 |
2021-01-08 | 25.2 | 2020-11-06 | 22.4 |
2021-01-07 | 25.2 | 2020-11-05 | 22.0 |
2021-01-06 | 25.1 | 2020-11-04 | 21.9 |
2021-01-05 | 24.9 | 2020-11-03 | 21.8 |
2021-01-04 | 24.6 | 2020-11-02 | 21.8 |
2021-01-01 | 24.8 | 2020-10-30 | 21.6 |
2020-12-31 | 24.8 | 2020-10-29 | 21.6 |
2020-12-30 | 24.5 | 2020-10-28 | 21.8 |
2020-12-29 | 24.2 | 2020-10-27 | 22.5 |
2020-12-28 | 24.1 | 2020-10-26 | 22.6 |
2020-12-25 | 24.0 | 2020-10-23 | 22.8 |
2020-12-24 | 24.0 | 2020-10-22 | 22.8 |
2020-12-23 | 23.9 | 2020-10-21 | 22.6 |
2020-12-22 | 24.0 | 2020-10-20 | 22.7 |
2020-12-21 | 24.1 | 2020-10-19 | 22.7 |
2020-12-18 | 24.3 | 2020-10-16 | 23.3 |
2020-12-17 | 24.2 | 2020-10-15 | 23.1 |
2020-12-16 | 23.5 | 2020-10-14 | 23.3 |
2020-12-15 | 23.7 | 2020-10-13 | 23.3 |
2020-12-14 | 23.4 | 2020-10-12 | 23.9 |
2020-12-11 | 24.1 | 2020-10-09 | 23.7 |
2020-12-10 | 23.9 | 2020-10-08 | 23.4 |
2020-12-09 | 24.1 | 2020-10-07 | 23.3 |
2020-12-08 | 23.8 | 2020-10-06 | 23.0 |
2020-12-07 | 23.4 | 2020-10-05 | 23.3 |
2020-12-04 | 23.6 | 2020-10-02 | 23.0 |
2020-12-03 | 23.4 | 2020-10-01 | 23.2 |
2020-12-02 | 23.3 | 2020-09-30 | 23.4 |
2020-12-01 | 23.2 | 2020-09-29 | 23.1 |
2020-11-30 | 22.8 | 2020-09-28 | 23.1 |
2020-11-27 | 22.6 | 2020-09-25 | 25.6 |
2020-11-26 | 22.6 | 2020-09-24 | 25.4 |
2020-11-25 | 22.6 | 2020-09-23 | 25.4 |
2020-11-24 | 22.6 | 2020-09-22 | 25.3 |
2020-11-23 | 22.6 | 2020-09-21 | 25.5 |
2020-11-20 | 23.0 | 2020-09-18 | 26.2 |
Johnson & Johnson PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Compare
NYSE:PFE
NYSE:MRK
NYSE:ABBV
NYSE:LLY
NYSE:BMY
NAS:AMGN
NAS:GILD
NYSE:AGN
NAS:BIIB
NAS:HZNP
XSWX:ROG
XSWX:NOVN
LSE:AZN
XPAR:SAN
LSE:GSK
TSE:4519
FRA:A60
XTER:BAYN
SHSE:600276
TSE:4568
Traded in other countries
JNJ.Argentina
JNJ.Austria
JNJB34.Brazil
JNJ.Chile
JNJ.Germany
JNJ.Mexico
JNJ.Peru
JNJ.Switzerland
0R34.UK
JNJ.USA
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.